Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara L Becker

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Current Opinion in Rheumatology|August 16, 2021
Safety updates in novel therapeutics for pediatric rheumatic diseaseRachel L Randell, Mara L Becker
Pediatrics|March 7, 2019
Improving the Safety of Teratogen Prescribing Practices in a Pediatric Rheumatology ClinicAshley M Cooper, Mara Horwitz, Mara L Becker
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 11, 2025
Plasma metabolic profiling identifies elevated hippurate as a potential biomarker of methotrexate non-response in juvenile idiopathic arthritisAmar Kumar, Mara L Becker, Ryan S Funk
Clinical and Translational Science|October 26, 2019
Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate In VitroRyan S Funk, Rakesh K Singh, Mara L Becker
Arthritis Care & Research|April 27, 2026
The Physician-Scientist Pipeline for Pediatric Rheumatology - Current Landscape and Future PerspectivesEkemini A Ogbu, Linda T Hiraki, Mara L Becker
Pharmacotherapy|May 6, 2017
Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic ArthritisRyan S Funk, Marcia A Chan, Mara L Becker
Pediatric Rheumatology Online Journal|September 21, 2016
Decreasing patient cost and travel time through pediatric rheumatology telemedicine visitsElizabeth A Kessler, Ashley K Sherman, Mara L Becker
American Journal of Perinatology|June 26, 2019
Neonatal Therapeutics: Considerations for DosingKanecia O Zimmerman, Daniel K Benjamin, Mara L Becker
Paediatric Drugs|December 15, 2018
Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary HospitalsJordan T Jones, Nasreen Talib, Daniel Lovell, et al.
Arthritis Care & Research|November 26, 2020
Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and OutcomesJordan T Jones, Chelsey Smith, Mara L Becker, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Current Opinion in Rheumatology|August 16, 2021
Safety updates in novel therapeutics for pediatric rheumatic diseaseRachel L Randell, Mara L Becker
Pediatrics|March 7, 2019
Improving the Safety of Teratogen Prescribing Practices in a Pediatric Rheumatology ClinicAshley M Cooper, Mara Horwitz, Mara L Becker
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 11, 2025
Plasma metabolic profiling identifies elevated hippurate as a potential biomarker of methotrexate non-response in juvenile idiopathic arthritisAmar Kumar, Mara L Becker, Ryan S Funk
Clinical and Translational Science|October 26, 2019
Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate In VitroRyan S Funk, Rakesh K Singh, Mara L Becker
Arthritis Care & Research|April 27, 2026
The Physician-Scientist Pipeline for Pediatric Rheumatology - Current Landscape and Future PerspectivesEkemini A Ogbu, Linda T Hiraki, Mara L Becker
Pharmacotherapy|May 6, 2017
Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic ArthritisRyan S Funk, Marcia A Chan, Mara L Becker
Pediatric Rheumatology Online Journal|September 21, 2016
Decreasing patient cost and travel time through pediatric rheumatology telemedicine visitsElizabeth A Kessler, Ashley K Sherman, Mara L Becker
American Journal of Perinatology|June 26, 2019
Neonatal Therapeutics: Considerations for DosingKanecia O Zimmerman, Daniel K Benjamin, Mara L Becker
Paediatric Drugs|December 15, 2018
Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary HospitalsJordan T Jones, Nasreen Talib, Daniel Lovell, et al.
Arthritis Care & Research|November 26, 2020
Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and OutcomesJordan T Jones, Chelsey Smith, Mara L Becker, et al.
Pageof 8